Future Trends In Cancer V3 - Aci - Sd

Acute Event

Prevention Screening

Diagnosis

Monitoring Treatment Plus

Chronic Disease

Future of Cancer:

Emerging Technology Trends Impacting Cancer Care

Ogan Gurel, MD MPhil Aesis Research Group, LLC

[email protected]

ACI Cancer Conference San Diego February 9th, 2007

Outline 

Change



The Future of Cancer



Impact on Cancer Care

Competitive forces cause change •Hospitals / ASCs • Relaxation of CON • Aging of the population •Emphasis of baby-boomers on convenience and seamlessness

• Growing influence of device companies

• Consumer-directed health plans

• Relative physician/surgeon shortages

• Growing influence of Federal government

• Physician work-life balance issues

• Emphasis on quality measures • BBA II?

• Technology convergence • Convergence of diagnosis and treatment Source: Porter, Michael, On Competition, 1995

• Emerging technologies

Change can be incremental or disruptive

Source: Christensen, Clayton et al, Seeing What’s Next, 2004

Outline 

Change



The Future of Cancer



Impact on Cancer Care

The hospital as center of care

Acute Event Diagnosis

Chronic Disease

Treatment

Care is now decentralized and fragmented Acute Event

Prevention

Screening

Diagnosis

Monitoring

Treatment Plus

Chronic Disease

The future will demand more integration and coordination Prevention

Acute Event

Screening

Chronic Disease

Diagnosis

SubDiagnosis

Treatment Plus

Monitoring

Substitutes

• Technology convergence • Convergence of diagnosis and treatment Source: Porter, Michael, On Competition, 1995

• Emerging technologies – esp. disruptive ones

Key disruptive technologies 

Earlier Diagnosis



Targeted therapies



Personalized Medicine



Minimally Invasive Surgery/Intervention

Outline 

Change



The Future of Cancer



Impact on Cancer Care

Imperatives for Future Cancer Care 

Provide coordinated, seamless care among multi-specialty providers



Address increasingly complex conditions and must address more than just the medical / surgical problem



Consider alliances and partnerships to help address these challenges



Measure quality



“Ride the IT wave” or be rendered irrelevant



Increasingly consider the integration of imaging (and diagnosis) with therapeutic care cases



Be increasingly aware that the federal government (Medicare, etc.) are not just “bystanders” in the process. Regulation and compliance are critical



Keep costs down – reimbursements will not be increasing and may very well decrease (though without compromising quality)



Keep physicians happy … which is not always about money



Be flexible enough to accommodate technology changes

Æsis Research Group Ogan Gurel, MD MPhil Chairman Providing forward-looking information, intelligence and research services to healthcare investment decision-makers Facilitating hospital-clinician relationships to help implement and move forward strategic, operational and facilities initiatives T (312) 246-5160| F (773) 409-5897

[email protected]